Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001437749-26-002120·Nuo Therapeutics, Inc.
Schedule 13D ownership disclosure
NUO THERAPEUTICS INC
Common Stock, $0.0001 par value per share · CUSIP: 67059V209
Event date: 2026-01-23
- Filing-level shares
- 5,610,050.00
- Percent of class
- 11.6%
- Pittman Scott M.Reported CIK 0001674752
Shares: 5,610,050.00 · Class: 11.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-26-002120
- Form type
- SCHEDULE 13D/A
- Filer
- Nuo Therapeutics, Inc.
- CIK
- CIK 1091596
- Filed
- Jan 26, 2026
- Reporting period
- Jan 23, 2026
- Description
- Schedule 13D beneficial ownership